Adequate baseline and post-treatment data were available on 26 patients, but two were excluded due to an unexplained borderline-low vWF antigen level at baseline or the occurrence of a line-related thrombosis during CYT997 infusion. The gene discussed is VWF; the disease is deep vein thrombosis.